Skip to content

Effectiveness of an Online Religiously-integrated Cognitive Behavioral Therapy-based Intervention on Death Anxiety

Investigating the Effectiveness of an Online Religiously-integrated Cognitive Behavioral Therapy-based Intervention on Death Anxiety

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06876103
Acronym
RCBT-DA
Enrollment
44
Registered
2025-03-14
Start date
2025-06-01
Completion date
2025-12-01
Last updated
2025-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Death Anxiety

Keywords

death anxiety, religiously integrated cognitive behavioral therapy, classical cognitive behavioral therapy, randomized control study

Brief summary

There has been growing awareness of the importance of death anxiety (DA) in pathological anxiety. DA is defined as a persistent and unreasonable fear of death and thoughts, fears, and emotions associated with the end of life. DA has been suggested as a core fear that underpins the emergence and perseverance of numerous anxiety disorders. However, previous DA-based treatment studies focus on the elderly, the patients, or health professionals who care for the terminally ill. Therefore, there is a need to examine the effect of psychological interventions on DA and current disorder symptoms in a clinical sample through randomized controlled trials. The current study aims to develop a novel Religiously Integrated Cognitive Behavioral Therapy (RCBT)-based intervention on DA in individuals diagnosed with an anxiety disorder and to compare the effectiveness of RCBT-based intervention with classical CBT-based intervention.

Detailed description

Religion facilitates the pursuit of symbolic immortality by providing individuals with purpose and hope in both life and death. Those who believe in an afterlife also see their world as fairer, which results in lower levels of psychiatric symptoms. Previous CBT-based death anxiety interventions did not consider the assumption of an afterlife. RCBT is an approach that integrates spiritual or religious beliefs into the therapeutic process. RCBT is an approach that recognizes the importance of spirituality or religion in a client's life and aims to use these beliefs and practices positively within the context of evidence-based CBT. Briefly, no intervention studies have investigated the effect of RCBT on DA. This will be the first study to develop an RCBT-based intervention for DA.

Interventions

OTHERReligiously-integrated Cognitive Behavioral Therapy

This study aims to assess the efficacy and feasibility of a newly developed online intervention for death anxiety based on Religiously Integrated Cognitive Behavioral Therapy (RCBT). Building upon the framework of Furer and Walker's 2008 intervention protocol, this adaptation incorporates beliefs in an afterlife, aligning with Turkish society's cultural and religious values. The RCBT intervention consists of seven structured group therapy sessions, each lasting 90 minutes. The program is designed to help participants identify and challenge unhelpful thoughts related to death anxiety while integrating religious resources to promote cognitive restructuring. Key components of the intervention include psychoeducation, cognitive restructuring, exposure exercises, the concept of repentance in the context of trust and belief in the afterlife, gratitude, and value-oriented behaviors.

OTHERClassical Cognitive Behavioral Therapy

The standard CBT intervention follows the structured protocol developed by Furer and Walker (2008), which targets cognitive distortions, avoidance behaviors, and excessive safety-seeking behaviors contributing to death anxiety. The researcher has adapted the session content to fit the protocol's core components while maintaining fidelity to the original intervention model. Sessions last 90 minutes and are conducted in an online group format. Session Structure: Session 1: Treatment Rationale, Session 2: Reducing Excessive Checking, Reassurance Seeking, and Safety Behaviors, Session 3: Exposure, Session 4: Cognitive Reappraisal, Session 5: Enhancing Enjoyment of Life, Session 6: Healthy Lifestyle, and Session 7: Relapse Prevention.

Sponsors

Ibn Haldun University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will be blinded to whether they are receiving religiously integrated CBT (RCBT) or classic CBT. Additionally, the outcomes assessor will be blinded to participants' pre- and post-treatment scale scores. However, the therapist conducting the intervention will be aware of the treatment allocation. Therefore, the study follows a single-blind design.

Intervention model description

This study employs a parallel assignment design, where participants are randomly allocated to either the intervention or control group to compare treatment effects.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18-65 * A score of \> 26 on the Turkish Death Anxiety Scale * Diagnosed with one of the anxiety disorders * Believing in life after death

Exclusion criteria

* Diagnosed with schizophrenia, schizophreniform disorder, schizoaffective disorder, and delusional disorder * Being in an active manic episode * Possessing a mental disorder that interferes with completing measures or understanding the exercises conducted during sessions * Extreme symptoms of depression (score of \> 20 on the Patient Health Questionnaire (PHQ-9), and \>1 on the item assessing suicidality) * Currently receiving therapy.

Design outcomes

Primary

MeasureTime frameDescription
Turkish Death Anxiety Scale (TDAS)Baseline (pretest), Week 7 (posttest), 3-month follow-upThe Turkish Death Anxiety Scale consists of 20 items that are divided into three subscales: (a) ambiguity of death, (b) exposure to death, and (c) agony of death. These subscales exhibit strong internal consistency, with Cronbach's alpha values of .91, .94, .76 respectively, adding up to a total of .95). It consists of a five-point Likert (0 = Never to 4 = Always). Subscale scores are determined by summing the individual item scores, and the total scale score is determined by summing the subscale scores. Total scale scores can be between 0 and 80, and the higher the score, the greater the level of DA. A score range of 0-7 indicates very low-level DA, 8-25 indicates low-level DA, 26-44 indicates medium-level DA, 45-63 indicates high-level DA, and 64-80 indicates very high-level DA.
Abdel-Khalek's Death Anxiety Scale (ASDA)Baseline (pretest), Week 7 (posttest), 3-month follow-upAbdel-Khalek's Death Anxiety Scale is a 20-item questionnaire that measures DA. The scale is one-dimensional. Higher scores indicate a greater degree of DA. It consists of a five-point Likert (1 = No to 5 = Very much). The Turkish reliability and validity of the scale were conducted by Sarıçiçek-Aydoğan et al. in 2015 (Cronbach's alpha = .86).

Secondary

MeasureTime frameDescription
Generalized Anxiety Disorder-7 (GAD-7)Baseline (pretest), Week 7 (posttest), 3-month follow-upGeneralized Anxiety Disorder-7 consists of a four-point Likert (0 = never to3 = almost every day) and 7 items that assess anxiety symptoms. The highest score that can be attained ranges up to 21. A score range of 0-4 indicates mild anxiety, 5-9 indicates moderate anxiety, 10-14 indicates high anxiety, and 15-21 indicates severe anxiety. A cut-off point of 10 points was determined for the total score. The Turkish reliability and validity of the scale were conducted by Konkan et al. in 2013 (Cronbach's alpha = .85).
Patient Health Questionnaire (PHQ-9)Baseline (pretest), Week 7 (posttest), 3-month follow-upPatient Health Questionnaire consists of a four-point Likert and nine items that screen depressive symptoms. Each of these items is rated on a scale of 0 (never) to 3 (almost every day). The highest score that can be attained ranges up to 27. A score range of 1-4 indicates low depressive symptoms, 5-9 indicates mild depressive symptoms, 10-14 indicates moderate depressive symptoms, 15-19 indicates partially severe depressive symptoms, and 20-27 indicates severe depressive symptoms. The Turkish reliability and validity of the scale were conducted by Sarı et al. (2016) (Cronbach's alpha = .84).

Other

MeasureTime frameDescription
Belief in a Day of Judgment ScaleBaseline (pretest), Week 7 (posttest), 3-month follow-upThe Belief in a Day of Judgment Scale comprises 20 items with two subscales: (1) belief in a day of judgment, and (2) bad behavior/actions toward others. It consists of a five-point Likert (1 = Strongly disagree to 5 = Strongly agree). Examples of the items include, God is the savior and judge of mankind., and If I am pure of heart and hands, I shall live in the fear of a just God. A high score on the Belief in a Day of Judgment subscale indicates a strong belief in a Day of Judgment, the conviction that God will judge the living and the dead, and the belief in life after death. A high score on the Bad Behavior/Actions Toward Others subscale reflects the belief that human relationships and actions towards others will be scrutinized on the Day of Judgment. The Turkish reliability and validity of the scale were conducted by Turan et al. in 2020 (Cronbach's alpha = .92).
Muslim Practice and Belief ScaleBaseline (pretest), Week 7 (posttest), 3-month follow-upThe Muslim Practice and Belief Scale- Short Form comprises nine items with two subscales: (1) social beliefs and prayers, and (2) individual beliefs and prayers subscale (PF). It consists of a five-point Likert (1 = Strongly Disagree to 5 = Strongly Agree). The Turkish reliability and validity of the scale were conducted by Akın and Yalnız in 2015 (Cronbach's alpha = .90). The subscales demonstrate good internal consistency, with Cronbach's alphas of. 86 and .91 respectively. Higher scores indicate a greater level of Muslim practice and belief.

Countries

Turkey (Türkiye)

Contacts

Primary ContactBüşra Kavla, PhD Student
busra.kavla@stu.ihu.edu.tr00905435978136
Backup ContactBurcu Uysal, Associate Professor
burcu.uysal@ihu.edu.tr00905365150970

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026